NBP – novabridge biosciences - american depositary shares (US:NASDAQ)

News

NovaBridge Appoints Mark Hagler as President and Chief Commercial Officer to Advance Commercial Strategy and Maximize Pipeline Value
NovaBridge's Givastomig Could Drive A Major Re-Rating [Seeking Alpha]
I-Mab (NBP) had its "buy" rating reaffirmed by HC Wainwright. They now have a $9.00 price target on the stock.
NovaBridge Reports Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
I-Mab Biopharma GAAP EPS of -$0.48 [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com